Developing vaccines for biodefense and emerging infectious diseases
Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
This study is working on new vaccines to help protect people from serious infections that could come from natural outbreaks or intentional releases, and it aims to make sure these vaccines are safe and effective for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Access to Advanced Health Institute NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11041315 on NIH RePORTER |
What this research studies
This research focuses on creating advanced vaccine candidates to protect against infectious diseases that may arise from natural outbreaks or intentional releases. The approach includes formulating and manufacturing vaccine components, conducting stability tests, and evaluating their effectiveness in animal models. The research also involves ensuring the safety and efficacy of these vaccines through rigorous clinical assessments and regulatory submissions. Patients may benefit from the development of these vaccines as they could provide protection against serious infectious threats.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals at risk of exposure to emerging infectious diseases or those living in areas prone to outbreaks.
Not a fit: Patients who are not at risk for emerging infectious diseases or those who have contraindications to vaccination may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that protect patients from emerging infectious diseases and bioterrorism threats.
How similar studies have performed: Previous research has shown success in developing vaccines for infectious diseases using similar methodologies, indicating a promising potential for this approach.
Where this research is happening
Seattle, United States
- Access to Advanced Health Institute — Seattle, United States (Active)
Researchers
- Principal investigator: Casper, Corey — Access to Advanced Health Institute
- Study coordinator: Casper, Corey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.